Cargando…
Analysis of the Clinical and Epidemiological Meaning of Screening Test for SARS-CoV-2: Considerations in the Chronic Kidney Disease Patients during the COVID-19 Pandemic
The COronaVIrus Disease 19 (COVID-19) pandemic is an emerging reality in nephrology. In a continuously changing scenario, we need to assess our patients’ additional risk in terms of attending hemodialysis treatments, follow-up peritoneal dialysis, and kidney transplant visits. The prevalence of seve...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963145/ https://www.ncbi.nlm.nih.gov/pubmed/33803083 http://dx.doi.org/10.3390/jcm10051139 |
_version_ | 1783665574700646400 |
---|---|
author | Martino, Francesca Amici, Gianpaolo Grandesso, Stefano Ferraro Mortellaro, Rosella Lo Cicero, Antonina Novara, Giacomo |
author_facet | Martino, Francesca Amici, Gianpaolo Grandesso, Stefano Ferraro Mortellaro, Rosella Lo Cicero, Antonina Novara, Giacomo |
author_sort | Martino, Francesca |
collection | PubMed |
description | The COronaVIrus Disease 19 (COVID-19) pandemic is an emerging reality in nephrology. In a continuously changing scenario, we need to assess our patients’ additional risk in terms of attending hemodialysis treatments, follow-up peritoneal dialysis, and kidney transplant visits. The prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-20 infection in the general population plays a pivotal role in estimating the additional COVID-19 risk in chronic kidney disease (CKD) patients. Unfortunately, local prevalence is often obscure, and when we have an estimation, we neglect the number of asymptomatic subjects in the same area and, consequently, the risk of infection in CKD patients. Furthermore, we still have the problem of managing COVID-19 diagnosis and the test’s accuracy. Currently, the gold standard for SARS-CoV-2 detection is a real-time reverse transcription-polymerase chain reaction (rRT-PCR) on respiratory tract samples. rRT-PCR presents some vulnerability related to pre-analytic and analytic problems and could impact strongly on its diagnostic accuracy. Specifically, the operative proceedings to obtain the samples and the different types of diagnostic assay could affect the results of the test. In this scenario, knowing the local prevalence and the local screening test accuracy helps the clinician to perform preventive measures to limit the diffusion of COVID-19 in the CKD population. |
format | Online Article Text |
id | pubmed-7963145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79631452021-03-17 Analysis of the Clinical and Epidemiological Meaning of Screening Test for SARS-CoV-2: Considerations in the Chronic Kidney Disease Patients during the COVID-19 Pandemic Martino, Francesca Amici, Gianpaolo Grandesso, Stefano Ferraro Mortellaro, Rosella Lo Cicero, Antonina Novara, Giacomo J Clin Med Review The COronaVIrus Disease 19 (COVID-19) pandemic is an emerging reality in nephrology. In a continuously changing scenario, we need to assess our patients’ additional risk in terms of attending hemodialysis treatments, follow-up peritoneal dialysis, and kidney transplant visits. The prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-20 infection in the general population plays a pivotal role in estimating the additional COVID-19 risk in chronic kidney disease (CKD) patients. Unfortunately, local prevalence is often obscure, and when we have an estimation, we neglect the number of asymptomatic subjects in the same area and, consequently, the risk of infection in CKD patients. Furthermore, we still have the problem of managing COVID-19 diagnosis and the test’s accuracy. Currently, the gold standard for SARS-CoV-2 detection is a real-time reverse transcription-polymerase chain reaction (rRT-PCR) on respiratory tract samples. rRT-PCR presents some vulnerability related to pre-analytic and analytic problems and could impact strongly on its diagnostic accuracy. Specifically, the operative proceedings to obtain the samples and the different types of diagnostic assay could affect the results of the test. In this scenario, knowing the local prevalence and the local screening test accuracy helps the clinician to perform preventive measures to limit the diffusion of COVID-19 in the CKD population. MDPI 2021-03-09 /pmc/articles/PMC7963145/ /pubmed/33803083 http://dx.doi.org/10.3390/jcm10051139 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Martino, Francesca Amici, Gianpaolo Grandesso, Stefano Ferraro Mortellaro, Rosella Lo Cicero, Antonina Novara, Giacomo Analysis of the Clinical and Epidemiological Meaning of Screening Test for SARS-CoV-2: Considerations in the Chronic Kidney Disease Patients during the COVID-19 Pandemic |
title | Analysis of the Clinical and Epidemiological Meaning of Screening Test for SARS-CoV-2: Considerations in the Chronic Kidney Disease Patients during the COVID-19 Pandemic |
title_full | Analysis of the Clinical and Epidemiological Meaning of Screening Test for SARS-CoV-2: Considerations in the Chronic Kidney Disease Patients during the COVID-19 Pandemic |
title_fullStr | Analysis of the Clinical and Epidemiological Meaning of Screening Test for SARS-CoV-2: Considerations in the Chronic Kidney Disease Patients during the COVID-19 Pandemic |
title_full_unstemmed | Analysis of the Clinical and Epidemiological Meaning of Screening Test for SARS-CoV-2: Considerations in the Chronic Kidney Disease Patients during the COVID-19 Pandemic |
title_short | Analysis of the Clinical and Epidemiological Meaning of Screening Test for SARS-CoV-2: Considerations in the Chronic Kidney Disease Patients during the COVID-19 Pandemic |
title_sort | analysis of the clinical and epidemiological meaning of screening test for sars-cov-2: considerations in the chronic kidney disease patients during the covid-19 pandemic |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963145/ https://www.ncbi.nlm.nih.gov/pubmed/33803083 http://dx.doi.org/10.3390/jcm10051139 |
work_keys_str_mv | AT martinofrancesca analysisoftheclinicalandepidemiologicalmeaningofscreeningtestforsarscov2considerationsinthechronickidneydiseasepatientsduringthecovid19pandemic AT amicigianpaolo analysisoftheclinicalandepidemiologicalmeaningofscreeningtestforsarscov2considerationsinthechronickidneydiseasepatientsduringthecovid19pandemic AT grandessostefano analysisoftheclinicalandepidemiologicalmeaningofscreeningtestforsarscov2considerationsinthechronickidneydiseasepatientsduringthecovid19pandemic AT ferraromortellarorosella analysisoftheclinicalandepidemiologicalmeaningofscreeningtestforsarscov2considerationsinthechronickidneydiseasepatientsduringthecovid19pandemic AT lociceroantonina analysisoftheclinicalandepidemiologicalmeaningofscreeningtestforsarscov2considerationsinthechronickidneydiseasepatientsduringthecovid19pandemic AT novaragiacomo analysisoftheclinicalandepidemiologicalmeaningofscreeningtestforsarscov2considerationsinthechronickidneydiseasepatientsduringthecovid19pandemic |